The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 24, 2007
Filed:
Jan. 29, 2004
Carl A. Aufdermarsh, Asheville, NC (US);
Harshad P. Amin, New Braunfels, TX (US);
Anestis Logothetis, Wilmington, DE (US);
Victor Gubanov, St. Petersburg, RU;
Margarita Volkova, St. Petersburg, RU;
Lioudmila Karmanova, St. Petersburg, RU;
Alexandr Kollar, St. Petersburg, RU;
Polina Troichanskaia, St. Petersburg, RU;
Gennady Emelianov, St. Petersburg, RU;
Vsevolod Berenblit, Leningrad Region, RU;
Carl A. Aufdermarsh, Asheville, NC (US);
Harshad P. Amin, New Braunfels, TX (US);
Anestis Logothetis, Wilmington, DE (US);
Victor Gubanov, St. Petersburg, RU;
Margarita Volkova, St. Petersburg, RU;
Lioudmila Karmanova, St. Petersburg, RU;
Alexandr Kollar, St. Petersburg, RU;
Polina Troichanskaia, St. Petersburg, RU;
Gennady Emelianov, St. Petersburg, RU;
Vsevolod Berenblit, Leningrad Region, RU;
Greene, Tweed of Delaware, Inc., Wilmington, DE (US);
Federal State Unitary Enterprise S.V. Lebedev Institute of Synthetic Rubber, St. Petersburg, RU;
Abstract
Novel monoamidine, monoamidoxime and bisamidine curatives, co-curatives and cure accelerators are provided for use with perfluoroelastomeric compositions as well as novel synthesis methods for making monoamidine- and monoamidoxime-based curatives, co-curatives and cure accelerators. Also provided are diphenyl-based curatives, co-curatives and cure accelerators having sufficiently high molecular weight such that the melting temperature of the curatives, co-curatives and cure accelerators is no greater than about 240° C., and more preferably no greater than about 230° C.